STAASTAAR Surgical Company
$21.68-20% 1Y
$21.68
$16.1052 weeks$33.34
The financials
STAAR Surgical Company by the numbers
STAAR Surgical Company (STAA) reported revenue of $94M in Q2 2026 (quarter ended Jul 3, 2026), up 111% from the same quarter a year earlier. That came with a gross margin of 75% and net income of $8.1M (8.6% of revenue). For the full year FY2025, revenue was $239M (−24% year on year) and net income −$80M. Its largest region in Q2 2026 was Other Countries at $20M, 44% of the disclosed total, ahead of Japan at 25%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $94M | $44M | +111% |
| Gross profit | $70M | $33M | +113% |
| Operating income | $10M | −$30M | to a profit |
| Net income | $8.1M | −$17M | to a profit |
| Diluted EPS | $0.16 | −$0.34 | to a profit |
| Geographic | Revenue | Share |
|---|---|---|
| Other Countries | $20M | 44% |
| Japan | $11M | 25% |
| China | $9.5M | 21% |
| South Korea | $4.3M | 9.6% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $44.7M (-14%)
China grew +242% year on yearSouth Korea +0.09% year on year
Segment Latestquarter on quarteryear on year
- Other Countries$19.7M$19.7Mquarter on quarter +2.8%year on year +8.4%+2.8%+8.4%
- Japan$11.1M$11.1Mquarter on quarter -9.2%year on year +2.1%-9.2%+2.1%
- China$9.5M$9.5Mquarter on quarter -25%year on year +242%-25%+242%
- South Korea$4.3M$4.3Mquarter on quarter -46%year on year +0.09%-46%+0.09%
Medical Instruments & Supplies
Ranks #9 of 21 by RyuScore